French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin
Status:
Completed
Trial end date:
2011-11-28
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this study is to extract data from the French
National Registry holding information about patients having initiated growth hormone therapy
with the objective to describe patients receiving growth hormone therapy, assess efficacy and
safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.